IRVINE, Calif. and PHOENIX, Sept. 14,
2020 /PRNewswire/ -- Today Allergan Aesthetics, an AbbVie
company (NYSE: ABBV), and Skinbetter Science®
announced the launch of a new long-term, educational initiative –
DREAM: Driving Racial Equity in Aesthetic
Medicine™. The DREAM Initiative™ is
committed to furthering the principles of racial and ethnic
diversity, inclusion, respect and understanding in the fields of
dermatology and plastic surgery.
"As leaders in aesthetics, Allergan Aesthetics and Skinbetter
Science are likeminded in our pursuit of advancing equality and
diversity in the aesthetics market and believe it is our
responsibility to create meaningful, positive change within our own
companies, and with our customers," stated Carrie Strom, Senior Vice President, AbbVie and
President, Global Allergan Aesthetics. "We are inaugurating
the DREAM Initiative™ with three important projects,
which will immediately expand available resources to enhance the
care of all patients, as well as to better diagnose and treat
dermatologic conditions across the full spectrum of skin types and
patients of color."
Case studies and data relevant to darker skin tones are grossly
underrepresented in current educational materials and textbooks
which can lead to under or misdiagnoses for black and brown
patients. Allergan Aesthetics and Skinbetter Science endeavor to
start to bridge this gap in dermatology and plastic surgery with
The National Racial Equity Medical Residency Curriculum. This
program is designed to assist students, faculty and staff in
dermatology and plastic surgery residency programs in identifying
and addressing the risk of implicit bias in academic and clinical
settings. This Curriculum is being piloted at a leading
university, with subsequent nationwide rollout planned
thereafter. The DREAM Initiative™ is also
sponsoring the development of The Spectrum of Dermatologic
Disease, a comprehensive textbook photo atlas, which will
present the characteristics of skin conditions across the full
range of racial and ethnic skin types. The Spectrum of
Dermatologic Disease, upon publication, will be disseminated to
medical residents, faculty and program libraries, and thereafter be
available as a resource for clinical practitioners worldwide.
The DREAM Initiative plans to convene Forces of Beauty™ Summits
to help identify different perceptions of beauty among racial and
ethnic groups, so that media, aesthetic providers and corporations
can better understand and meet the aesthetic needs of all
patients.
"Inspired by the nationwide peaceful protests that have
galvanized our communities in calling for racial equity in all
sectors of society, Skinbetter Science and Allergan Aesthetics
wanted to identify ways in which we could leverage our collective
experience and knowledge to make a tangible contribution to
improving health equity," stated Jonah
Shacknai, Executive Chairman of Skinbetter Science.
"Helping to make aesthetics and dermatology more inclusive and
fair, and enabling physicians and healthcare providers to bring
that to life, is an important place to start."
About Skinbetter Science
The Skinbetter Science
team of aesthetic experts has a profound understanding of skin
aging and what it takes to help defy the effects of
time. Tapping into a rich dermatological heritage, the team at
Skinbetter Science set out to create a new paradigm in clinical
skincare. Cutting-edge, data-driven science is the principal
driving force behind all our unique
formulations. Skinbetter Science award-winning products
are available exclusively through the leading dermatology,
plastic surgery and medical aesthetics practices nationwide. For
more information, visit us at Skinbetter.com or follow us on
Facebook, Instagram and LinkedIn.
About Allergan Aesthetics
At Allergan Aesthetics, an
AbbVie company, we develop, manufacture, and market a portfolio of
leading aesthetics brands and products. Our aesthetics portfolio
includes facial injectables, body contouring, plastics, skin care,
and more. Our goal is to consistently provide our customers with
innovation, education, exceptional service, and a commitment to
excellence, all with a personal touch. For more information,
visit www.AllerganAesthetics.com or follow us on Instagram and
LinkedIn.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/allergan-aesthetics-and-skinbetter-science-announce-the-dream-initiative-to-advance-health-equity-and-diversity-in-aesthetics-301129697.html
SOURCE AbbVie